ES2157996T3 - Nueva composicion. - Google Patents

Nueva composicion.

Info

Publication number
ES2157996T3
ES2157996T3 ES94931943T ES94931943T ES2157996T3 ES 2157996 T3 ES2157996 T3 ES 2157996T3 ES 94931943 T ES94931943 T ES 94931943T ES 94931943 T ES94931943 T ES 94931943T ES 2157996 T3 ES2157996 T3 ES 2157996T3
Authority
ES
Spain
Prior art keywords
new composition
base
eter
surfactant
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94931943T
Other languages
English (en)
Inventor
Harvey Lee Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303736&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2157996(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939321876A external-priority patent/GB9321876D0/en
Priority claimed from GB939322288A external-priority patent/GB9322288D0/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of ES2157996T3 publication Critical patent/ES2157996T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA O VETERINARIA QUE CONTIENE UNA BASE DE CREMA CUYA BASE CONTIENE UN ACEITE MINERAL; UNO O MAS ALCOHOLES GRASOS O ESTERES GRASOS; UN SURFACTANTE DE ESTER O DE ETER DE POLIOXIETILENO; Y AGUA.
ES94931943T 1993-10-22 1994-10-20 Nueva composicion. Expired - Lifetime ES2157996T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321876A GB9321876D0 (en) 1993-10-22 1993-10-22 Novel composition
GB939322288A GB9322288D0 (en) 1993-10-29 1993-10-29 Novel composition

Publications (1)

Publication Number Publication Date
ES2157996T3 true ES2157996T3 (es) 2001-09-01

Family

ID=26303736

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94931943T Expired - Lifetime ES2157996T3 (es) 1993-10-22 1994-10-20 Nueva composicion.

Country Status (27)

Country Link
US (1) US6025389A (es)
EP (1) EP0727979B1 (es)
JP (1) JPH09506865A (es)
KR (1) KR100374462B1 (es)
CN (1) CN1102410C (es)
AP (1) AP608A (es)
AT (1) ATE202467T1 (es)
AU (1) AU692486B2 (es)
BG (1) BG62912B1 (es)
BR (1) BR9407840A (es)
CA (1) CA2174658C (es)
CZ (1) CZ292223B6 (es)
DE (1) DE69427589T2 (es)
DK (1) DK0727979T3 (es)
ES (1) ES2157996T3 (es)
FI (1) FI116931B (es)
GR (1) GR3036591T3 (es)
HU (1) HU221853B1 (es)
NO (1) NO313446B1 (es)
NZ (1) NZ275282A (es)
OA (1) OA10361A (es)
PL (1) PL177592B1 (es)
PT (1) PT727979E (es)
RO (1) RO112987B1 (es)
SK (1) SK280222B6 (es)
UA (1) UA39896C2 (es)
WO (1) WO1995010999A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ112499A3 (cs) * 1996-10-01 1999-08-11 Smithkline Beecham Corporation Použití mupirocinu k výrobě léčiva pro léčbu bakteriálních infekcí spojených s kolonizací nosohltanu patogenními organismy
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
CA2303443A1 (en) * 1997-09-11 1999-03-18 Anthony Guy Hatton Compositions adapted for prolonged residence in the nasal pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20040224981A1 (en) * 2003-05-01 2004-11-11 Nebojsa Janjic Antibacterial methods and compositions
US20050123575A1 (en) * 2003-12-03 2005-06-09 Eilon Asculai Spreadable compositions for topical use, an improved process of making same and methods of using same
WO2008007182A2 (en) * 2006-07-07 2008-01-17 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions of mupirocin or pharmaceutically acceptable salts or esters thereof
ES2703253T3 (es) 2010-03-30 2019-03-07 Helperby Therapeutics Ltd Nueva combinación y uso
WO2012017215A1 (en) 2010-08-05 2012-02-09 Helperby Therapeutics Limited Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine
GB201013207D0 (en) 2010-08-05 2010-09-22 Helperby Therapeutics Ltd Novel combination
GB201015079D0 (en) 2010-09-10 2010-10-27 Helperby Therapeutics Ltd Novel use
US20130245060A1 (en) 2010-10-08 2013-09-19 Helperby Therapeutics Limited Novel composition
US20140065209A1 (en) 2011-05-03 2014-03-06 Dupont Nutrition Biosciences Aps Probiotic bacteria for the topical treatment of skin disorders
GB201107755D0 (en) 2011-05-10 2011-06-22 Helperby Therapeutics Ltd Novel compounds
CN102335122B (zh) * 2011-06-21 2013-04-17 北京协和药厂 一种莫匹罗星软膏及其制备方法
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
GB201305277D0 (en) 2013-03-22 2013-05-01 Helperby Therapeutics Ltd Novel combination and use
GB201307989D0 (en) 2013-05-02 2013-06-12 Helperby Therapeutics Ltd Novel combinations and use
EP3082424B1 (en) 2013-12-17 2023-10-04 Hatchtech Pty Ltd Pediculicidal composition
GB201401617D0 (en) 2014-01-30 2014-03-19 Helperby Therapeutics Ltd Novel combination and use
CN107530397A (zh) 2014-12-18 2018-01-02 赫尔普百治疗有限公司 新型组合和用途
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
GB201518969D0 (en) 2015-10-27 2015-12-09 Helperby Therapeutics Ltd Triple combination
GB201620095D0 (en) 2016-11-28 2017-01-11 Terali Innov Sas And Univ De Strasbourg And Inserm (Inst Nat De La Sante Et De La Rech Medicale) And Novel use
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
CN109310626A (zh) 2016-04-19 2019-02-05 美利坚合众国,由健康及人类服务部部长代表 革兰氏阴性种治疗特应性皮炎的用途
GB201610869D0 (en) 2016-06-22 2016-08-03 Helperby Therapeutics Ltd Combination
GB201709193D0 (en) 2017-06-09 2017-07-26 Helperby Therapeutics Ltd Combination
WO2019141957A1 (en) 2018-01-19 2019-07-25 Cado Biotechnology Ivs N-pyrimidinyl hydroxy pyrazole derivatives and uses thereof
KR20210013080A (ko) 2018-05-11 2021-02-03 포르테 서브시디어리, 인크. 피부 병태의 치료를 위한 조성물
US10709663B2 (en) 2018-10-17 2020-07-14 Glenmark Pharmaceuticals, Inc., Usa Mupirocin cream in pump device
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
US20210299019A1 (en) * 2020-03-31 2021-09-30 Chemistryrx Methods for treating hyperpigmentation and compositions for same
BR112023020137A2 (pt) 2021-03-30 2023-11-28 Dupont Nutrition Biosci Aps Composições, comprimido, estojo e método para tratar e/ou prevenir a inflamação gastrointestinal
WO2025080755A1 (en) 2023-10-13 2025-04-17 Nutrition & Biosciences USA 4, Inc. Methods and compositions for aging and mitochondrial health

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US4847068A (en) * 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions

Also Published As

Publication number Publication date
SK49596A3 (en) 1997-02-05
DE69427589T2 (de) 2002-04-25
WO1995010999A1 (en) 1995-04-27
KR100374462B1 (ko) 2003-06-09
CN1102410C (zh) 2003-03-05
HU221853B1 (hu) 2003-02-28
NO961588L (no) 1996-04-19
DK0727979T3 (da) 2001-10-01
EP0727979A4 (en) 1996-11-27
DE69427589D1 (de) 2001-08-02
EP0727979B1 (en) 2001-06-27
SK280222B6 (sk) 1999-10-08
AP9600798A0 (en) 1996-04-30
BR9407840A (pt) 1997-05-13
US6025389A (en) 2000-02-15
RO112987B1 (ro) 1998-03-30
CZ292223B6 (cs) 2003-08-13
NO961588D0 (no) 1996-04-19
BG100501A (bg) 1996-12-31
FI961720A0 (fi) 1996-04-19
HK1012284A1 (en) 1999-07-30
CA2174658A1 (en) 1995-04-27
FI961720L (fi) 1996-04-19
EP0727979A1 (en) 1996-08-28
CN1135715A (zh) 1996-11-13
CA2174658C (en) 2000-12-19
AU692486B2 (en) 1998-06-11
FI116931B (fi) 2006-04-13
GR3036591T3 (en) 2001-12-31
NO313446B1 (no) 2002-10-07
PL177592B1 (pl) 1999-12-31
PT727979E (pt) 2001-11-30
AU8084794A (en) 1995-05-08
ATE202467T1 (de) 2001-07-15
BG62912B1 (bg) 2000-11-30
UA39896C2 (uk) 2001-07-16
PL314038A1 (en) 1996-08-05
AP608A (en) 1997-08-28
HUT74510A (en) 1997-01-28
JPH09506865A (ja) 1997-07-08
NZ275282A (en) 1996-10-28
HU9601030D0 (en) 1996-06-28
OA10361A (en) 2001-11-21
CZ112096A3 (en) 1996-07-17

Similar Documents

Publication Publication Date Title
ES2157996T3 (es) Nueva composicion.
NO940288L (no) Formuleringer inneholdende umettede fettsyrer
PT88270A (pt) Processo para a preparacao de esteres carboxi/carboxilato que emitam gorduras de baixo valor calorico, sua utilizacao e composicoes que os contem
FI941056A0 (fi) Kalsiumia ja polyhydroksirasvahappoamidia sisältäviä pesuainekoostumuksia
TR27593A (tr) Polihidroksi yagli asit amidleri ihtiva eden akiskan bilesimleri.
ES2139853T3 (es) Propiedades de las feromonas faciales de los gatos.
PT1105122E (pt) Composicoes farmaceuticas que contem inibidores de lipase
PT942721E (pt) Composicao liquida compreendendo um inibidor de protease de vih e um acido gordo c12-c18
NO975035D0 (no) Fettsyreestere som bioaktive forbindelser
IT1255895B (it) Composizioni farmaceutiche contenenti una calcitonina
FI922542L (fi) Fettsyrakompositioner
FI951250A7 (fi) Interleukiini-l-inhibiittorien farmaseuttiset formulaatiot
ATE285783T1 (de) Feste lipidformulierung enthaltend lipasehemmer und fettsäureester von polyolen
PT831826E (pt) Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
ID17964A (id) Pembuatan ester surfaktan
EP0596284A3 (de) Antimycotische kosmetische und dermatologische Zubereitungen mit einem Gehalt an Fettsäureestern.
MX9101845A (es) Composiciones antiplaca mejoradas que comprenden una combinacion de alcohol morfolinoamino y agente quelante
FI954346L (fi) Laite suonikohjujen ekstirpaatioon
BR9708031A (pt) Oleo hidráulico à base de ésteres de ácidos graxos naturais processo para a sua fabricação e uso de um material contendo éster de talóleo
NO930525L (no) Framgangsmaate for utvikling av umettede fettsyrer
MX9200843A (es) Esteres del acido acrilico triazinil-substituidos y procedimiento para su obtencion.
DK0718275T3 (da) Kvaternære triethanolaminfedtsyreestere
PT854842E (pt) Metodos e composicoes para combater as bioincrustacoes utilizando esteres poliglicolicos de acidos gordos
GB2311533B (en) Esters of polyunsaturated fatty acids
KR960036129U (ko) 컴퓨터모니터함의 자동승강장치

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 727979

Country of ref document: ES